Katherine S Bowdish - Net Worth and Insider Trading
Katherine S Bowdish Net Worth
The estimated net worth of Katherine S Bowdish is at least $29 Million dollars as of 2024-04-26. Katherine S Bowdish is the Senior Vice President of Alexion Pharmaceuticals Inc and owns about 160,784 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $29 Million. Details can be seen in Katherine S Bowdish's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Katherine S Bowdish has not made any transactions after 2005-06-15 and currently still holds the listed stock(s).
Transaction Summary of Katherine S Bowdish
Katherine S Bowdish Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Katherine S Bowdish owns 1 companies in total, including Alexion Pharmaceuticals Inc (ALXN) .
Click here to see the complete history of Katherine S Bowdish’s form 4 insider trades.
Insider Ownership Summary of Katherine S Bowdish
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-15 | Senior Vice President |
Katherine S Bowdish Latest Holdings Summary
Katherine S Bowdish currently owns a total of 1 stock. Katherine S Bowdish owns 160,784 shares of Alexion Pharmaceuticals Inc (ALXN) as of June 15, 2005, with a value of $29 Million.
Latest Holdings of Katherine S Bowdish
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals Inc | 2005-06-15 | 160,784 | 182.50 | 29,343,080 |
Holding Weightings of Katherine S Bowdish
Katherine S Bowdish Form 4 Trading Tracker
According to the SEC Form 4 filings, Katherine S Bowdish has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 12,000 shares on June 15, 2005, which brought Katherine S Bowdish around $64,710.
Insider Trading History of Katherine S Bowdish
- 1
Katherine S Bowdish Trading Performance
Katherine S Bowdish Ownership Network
Ownership Network List of Katherine S Bowdish
Ownership Network Relation of Katherine S Bowdish
Katherine S Bowdish Owned Company Details
What does Alexion Pharmaceuticals Inc do?
Who are the key executives at Alexion Pharmaceuticals Inc?
Katherine S Bowdish is the Senior Vice President of Alexion Pharmaceuticals Inc. Other key executives at Alexion Pharmaceuticals Inc include SVP & Controller & CAO Daniel Bazarko , EVP & CCAO Tanisha Carino , and EVP & Chief Commercial Officer Brian Goff .
Alexion Pharmaceuticals Inc (ALXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Alexion Pharmaceuticals Inc (ALXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Alexion Pharmaceuticals Inc (ALXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Alexion Pharmaceuticals Inc (ALXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alexion Pharmaceuticals Inc Insider Transactions
Katherine S Bowdish Mailing Address
Above is the net worth, insider trading, and ownership report for Katherine S Bowdish. You might contact Katherine S Bowdish via mailing address: C/o Alexion Pharmaceuticals Inc 352 Knotter Drive Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
